The purpose of the study is to determine the safety of HSV529 vaccine in healthy volunteers
with HSV infection and to determine if administration of the HSV529 vaccine increases the
immune response in genital skin.
Phase:
Phase 1
Details
Lead Sponsor:
Fred Hutchinson Cancer Research Center
Collaborators:
Sanofi Pasteur, a Sanofi Company University of Washington